XBIO vs. NNN

Last updated Jun 3, 2026

XBIO (Xenetic Biosciences, Inc.) and NNN (National Retail Properties, Inc.) are both stocks. XBIO operates in Biotechnology (Healthcare), while NNN operates in REIT - Retail (Real Estate). Over the past 10 years, XBIO returned -42.83%/yr vs 4.35%/yr for NNN. At a 0.06 correlation, their price movements are largely independent.

Performance

XBIO vs. NNN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Xenetic Biosciences, Inc. (XBIO) and National Retail Properties, Inc. (NNN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XBIO achieves a 55.76% return, which is significantly higher than NNN's 13.75% return. Over the past 10 years, XBIO has underperformed NNN with an annualized return of -42.83%, while NNN has yielded a comparatively higher 4.35% annualized return.

XBIO

• 1D: 2.11%
• 1M: 13.80%
• YTD: 55.76%
• 6M: 37.96%
• 1Y: 2.74%
• 3Y*: 1.95%
• 5Y*: -31.79%
• 10Y*: -42.83%

NNN

• 1D: 1.39%
• 1M: -0.30%
• YTD: 13.75%
• 6M: 11.01%
• 1Y: 11.04%
• 3Y*: 6.34%
• 5Y*: 3.59%
• 10Y*: 4.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

XBIO vs. NNN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
XBIO Xenetic Biosciences, Inc.	55.76%	-45.61%	15.65%	21.01%	-77.90%	-36.76%	41.67%	-92.68%	-14.54%	-55.37%
NNN National Retail Properties, Inc.	13.75%	2.81%	-0.06%	-0.60%	-0.01%	23.08%	-19.29%	14.78%	17.82%	2.00%

Correlation

The correlation between XBIO and NNN is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.00
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (10Y) Calculated over the trailing 10-year period	0.07
Correlation (All Time) Calculated using the full available price history since Jul 1, 2014	0.06

Fundamentals

Market Cap XBIO : $7.74M NNN : $8.30B
EPS XBIO : -$1.17 NNN : $2.05
PS Ratio XBIO : 2.03 NNN : 8.83
PB Ratio XBIO : 1.11 NNN : 1.89
Total Revenue (TTM) XBIO : $3.19M NNN : $935.78M
Gross Profit (TTM) XBIO : $2.38M NNN : $761.54M
EBITDA (TTM) XBIO : -$2.37M NNN : $870.06M

Return for Risk

XBIO vs. NNN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBIO

XBIO Risk / Return Rank: 51
XBIO Sharpe Ratio Rank: 40
XBIO Sortino Ratio Rank: 66
XBIO Omega Ratio Rank: 64
XBIO Calmar Ratio Rank: 44
XBIO Martin Ratio Rank: 42

NNN

NNN Risk / Return Rank: 60
NNN Sharpe Ratio Rank: 63
NNN Sortino Ratio Rank: 54
NNN Omega Ratio Rank: 52
NNN Calmar Ratio Rank: 65
NNN Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBIO vs. NNN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xenetic Biosciences, Inc. (XBIO) and National Retail Properties, Inc. (NNN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XBIO	NNN	Difference
Sharpe ratio Return per unit of total volatility	0.02	0.68	-0.66
Sortino ratio Return per unit of downside risk	1.59	1.05	+0.54
Omega ratio Gain probability vs. loss probability	1.19	1.12	+0.07
Calmar ratio Return relative to maximum drawdown	0.16	1.26	-1.10
Martin ratio Return relative to average drawdown	0.21	2.92	-2.70
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XBIO vs. NNN - Sharpe Ratio Comparison

The current XBIO Sharpe Ratio is 0.02, which is lower than the NNN Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of XBIO and NNN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XBIO	NNN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.02	0.68	-0.66
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.30	0.18	-0.48
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.32	0.16	-0.48
Sharpe Ratio (All Time) Calculated using the full available price history	-0.31	0.40	-0.71

Drawdowns

XBIO vs. NNN - Drawdown Comparison

The maximum XBIO drawdown since its inception was -99.95%, which is greater than NNN's maximum drawdown of -56.17%. Use the drawdown chart below to compare losses from any high point for XBIO and NNN.

Drawdown Indicators

	XBIO	NNN	Difference
Max Drawdown Largest peak-to-trough decline	-99.95%	-56.17%	-43.78%
Max Drawdown (1Y) Largest decline over 1 year	-80.50%	-8.83%	-71.67%
Max Drawdown (3Y) Largest decline over 3 years	-80.50%	-22.03%	-58.47%
Max Drawdown (5Y) Largest decline over 5 years	-96.19%	-25.22%	-70.97%
Max Drawdown (10Y) Largest decline over 10 years	-99.78%	-54.99%	-44.79%
Current Drawdown Current decline from peak	-99.91%	-3.27%	-96.64%
Average Drawdown Average peak-to-trough decline	-91.40%	-9.82%	-81.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	59.71%	3.82%	+55.89%

Volatility

XBIO vs. NNN - Volatility Comparison

Xenetic Biosciences, Inc. (XBIO) has a higher volatility of 12.74% compared to National Retail Properties, Inc. (NNN) at 4.53%. This indicates that XBIO's price experiences larger fluctuations and is considered to be riskier than NNN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XBIO	NNN	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.74%	4.53%	+8.21%
Volatility (6M) Calculated over the trailing 6-month period	51.15%	11.48%	+39.67%
Volatility (1Y) Calculated over the trailing 1-year period	168.93%	16.30%	+152.63%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	108.03%	19.67%	+88.36%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	134.15%	28.08%	+106.07%

Dividends

XBIO vs. NNN - Dividend Comparison

XBIO has not paid dividends to shareholders, while NNN's dividend yield for the trailing twelve months is around 5.48%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NNN National Retail Properties, Inc.	5.48%	5.96%	5.61%	5.17%	4.72%	4.37%	5.06%	3.79%	4.02%	4.31%	4.03%	4.27%
XBIO Xenetic Biosciences, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

XBIO vs. NNN - Profitability Comparison

The chart below illustrates the profitability comparison between Xenetic Biosciences, Inc. and National Retail Properties, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

XBIO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Xenetic Biosciences, Inc. reported a gross profit of 0.00 and revenue of 806.92K. Therefore, the gross margin over that period was 0.0%.

NNN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, National Retail Properties, Inc. reported a gross profit of 230.63M and revenue of 240.42M. Therefore, the gross margin over that period was 95.9%.

XBIO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Xenetic Biosciences, Inc. reported an operating income of -502.12K and revenue of 806.92K, resulting in an operating margin of -62.2%.

NNN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, National Retail Properties, Inc. reported an operating income of 146.65M and revenue of 240.42M, resulting in an operating margin of 61.0%.

XBIO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Xenetic Biosciences, Inc. reported a net income of -456.38K and revenue of 806.92K, resulting in a net margin of -56.6%.

NNN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, National Retail Properties, Inc. reported a net income of 93.95M and revenue of 240.42M, resulting in a net margin of 39.1%.

Frequently Asked Questions

Can I hold both XBIO and NNN in my portfolio?

XBIO and NNN have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XBIO or NNN?

XBIO has higher volatility (12.74%) compared to NNN (4.53%). In terms of maximum drawdown, XBIO dropped -99.95% vs NNN's -56.17%.

Which has better risk-adjusted returns?

NNN currently has the higher Sharpe Ratio (0.68 vs 0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.